Adelaide Research & Scholarship
Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/102063
| Citations | ||
| Scopus | Web of Science® | Altmetric |
|---|---|---|
|
?
|
?
|
|
| Type: | Journal article |
| Title: | PRISM: Phase 2 trial with panitumumab monotherapy as second-line treatment in patients with recurrent or metastatic squamous cell carcinoma of the head and neck |
| Author: | Rischin, D. Spigel, D. Adkins, D. Wein, R. Arnold, S. Singhal, N. Lee, O. Murugappan, S. |
| Citation: | Head and Neck: journal for the sciences and specialities of the head and neck, 2016; 38(S1):E1756-E1761 |
| Publisher: | Wiley |
| Issue Date: | 2016 |
| ISSN: | 1043-3074 1097-0347 |
| Statement of Responsibility: | Danny Rischin, David R. Spigel, Douglas Adkins, Richard Wein, Susanne Arnold, Nimit Singhal, Oliver Lee, Swami Murugappan |
| Abstract: | Abstract not available |
| Keywords: | recurrent or metastatic squamous cell carcinoma of the head and neck; panitumumab; Panitumumab Regimen In Secondline Monotherapy of Head and Neck Cancer (PRISM) trial; monotherapy; human papillomavirus (HPV); p16 |
| Description: | Published online 17 December 2015 |
| Rights: | © 2015 Wiley Periodicals, Inc. |
| DOI: | 10.1002/hed.24311 |
| Published version: | http://dx.doi.org/10.1002/hed.24311 |
| Appears in Collections: | Aurora harvest 3 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.